Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
3
4
5
6
7
8
9
10
11
13
14
15
16
17
18
19
20
21
22
23
25
26
27
29
30
1
2
3
4
02 Apr
2014-04-02    
All Day
Conference Link: http://www.nhlc-cnls.ca/default1.asp Conference Contact: Cindy MacBride at 1-800-363-9056 ext. 213, or cmacbride@cchl-ccls.ca Register: http://www.confmanager.com/main.cfm?cid=2725 Hotel: Location: Fairmont Banff Springs Hotel 405 Spray Ave Banff, [...]
HIMSS 15 Annual Conference & Exhibition
2014-04-12    
All Day
HIMSS15 may be months away, but the excitement is here...right now. It's not too early to start making plans for next April. Whether you're new [...]
2015 HIMSS Annual Conference & Exhibition
2014-04-12 - 2014-04-16    
All Day
The 2015 HIMSS Annual Conference & Exhibition, April 12-16 in Chicago, brings together 38,000+ healthcare IT professionals, clinicians, executives and vendors from around the world. [...]
IVC Miami Conference
The International Vein Congress is the premier professional meeting for vein specialists. IVC, based in Miami, FL, offers renowned, comprehensive education for both veterans and [...]
C.D. Howe Institute Roundtable Luncheon
2014-04-28    
12:00 pm - 1:30 pm
Navigating the Healthcare System: The Patient’s Perspective Please join us for this Roundtable Luncheon at the C.D. Howe Institute with Richard Alvarez, Chief Executive Officer, [...]
Events on 2014-04-02
Events on 2014-04-12
Events on 2014-04-24
IVC Miami Conference
24 Apr 14
FL
Events on 2014-04-28
Articles

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

amyotrophic lateral scelrosis

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

Amyotrophic lateral sclerosis (ALS) belongs to a group of neurological disease. Otherwise called motor neuron diseases, they influence the engine elements of voluntary muscles in the body. Factors, for example, an expansion in the occurrence rate of ALS, grow in the awareness about the ailment among patients, and ascend in the geriatric populace is relied upon to help the development of the amyotrophic lateral sclerosis market. Other factors including the tendency towards the stationary way of life are driving the market development and expanding the danger of getting attacked by ALS.

Furthermore, the expanding geriatric populace substantiates market development, making interest in symptomatic and focused on treatment alternatives. However, the staggering expense of the treatment of ALS may impede market development over the figure time frame.

The Amyotrophic lateral sclerosis market is growing at 7.89 % CAGR and is expected to reach the valuation of USD 841.6 million by the year 2023.

Major players

Mylan N.V. (U.S.), Covis Pharma (Switzerland), Ionis Pharmaceutical (U.S.), ITF Pharma (U.S.), Ascend Pharmaceuticals LLC (U.S.), Apotex Inc. (Canada), Sun Pharmaceutical (India), Mitsubishi Tanabe Pharma America (U.S.), Biogen (U.S.), Sanofi (France), among others are some of the major players in the Global amyotrophic lateral sclerosis market.

The Global amyotrophic lateral sclerosis market has been classified on the basis of its treatment, type, end-user, and regional demand. Based on its type, the market is classified into familial ALS and sporadic. Based on its treatment, the market has been segmented into physical therapy, speech therapy, medication, respiratory therapy, and others. By its end-user, the ALS market has been segmented into research & academic institutes, specialty centers, hospitals, and others.

Source inforgrowth.com/report/1850367/amyotrophic-lateral-sclerosis-market

About InForGrowth

At InForGrowth, Understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable and trusted publishing partners, we are paving way for a more simplified and relevant research.